Atlas FDA

DEXTRAN HM 32% HYSTEROSCOPIC DISTENTION MEDIUM

FDA premarket approval P880028/S008 · decided 1999-01-29

Approval details

PMA number
P880028
Supplement
S008
Supplement type
Normal 180 Day Track
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
DEXTRAN HM 32% HYSTEROSCOPIC DISTENTION MEDIUM
Generic name
FLUID, HYSTEROSCOPY
Applicant
Hospira, Inc.
Date received
1998-07-21
Decision date
1999-01-29
Days to decision
192 days
Decision code
APPR
Product code
LTA
Advisory committee
Obstetrics/Gynecology
Expedited review
No
Location
Lake Forest, IL
Statement
Approval for a change in the approved marketed product stability protocol for the Dextran HM 32% to delete 3 and 6 month test stations from the approved stability protocol.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Plum 360(TM) Infusion System with MedNet/ Smart Card Plug and Play Module (K161469)Hospira, Inc.2017-03-28
Hospira Extension Set, Hospira Primary Set (K161036)Hospira, Inc.2017-01-06
Hospira Sapphire Sets (K160492)Hospira, Inc.2016-12-06
Hospira Administration Sets (K160870)Hospira, Inc.2016-06-01
LifeCare PCA Infusion System (K143612)Hospira, Inc.2016-04-08
Hospira Blood Set (K143087)Hospira, Inc.2015-03-04
Hospira Primary Sets (K143015)Hospira, Inc.2015-02-25
PLUM 360 INFUSION SYSTEM WITH HOSPIRA MEDNET, SMART CARD PLUG N PLAY CE 3.0 MODULE FOR PLUM A+ INFUSION SYSTEM UPGRADE (K141789)Hospira, Inc.2015-01-16